» Articles » PMID: 36966471

Identification of the Veterinary Sedative Medetomidine in Combination with Opioids and Xylazine in Maryland

Overview
Journal J Forensic Sci
Specialty Forensic Sciences
Date 2023 Mar 26
PMID 36966471
Authors
Affiliations
Soon will be listed here.
Abstract

Public health, public safety, and forensic science personnel continue to face the emergence of new compounds into the drug market. While focus is often put on the detection of new analogs of known illicit drugs, monitoring the changes in cutting agents and other compounds can be equally as important. Over the last year, near real-time monitoring of the drug supply in Maryland has been completed through a public health-public safety partnership whereby residue from suspected drug packaging or used paraphernalia is collected and analyzed. Through this project, we have recently detected the presence of the veterinary sedative medetomidine in a small number of samples. The presence of medetomidine has been identified in both public health and law enforcement samples and in the presence of fentanyl and xylazine-another veterinary sedative that has been widely observed over the last year. While the rate at which medetomidine has been detected remains low, it is concerning and worthy of continued monitoring.

Citing Articles

Classics in Chemical Neuroscience: Medetomidine.

de Andrade Horn P, Berida T, Parr L, Bouchard J, Jayakodiarachchi N, Schultz D ACS Chem Neurosci. 2024; 15(21):3874-3883.

PMID: 39405508 PMC: 11587509. DOI: 10.1021/acschemneuro.4c00583.


Notes from the Field: Detection of Medetomidine Among Patients Evaluated in Emergency Departments for Suspected Opioid Overdoses - Missouri, Colorado, and Pennsylvania, September 2020-December 2023.

Schwarz E, Buchanan J, Aldy K, Shulman J, Krotulski A, Walton S MMWR Morb Mortal Wkly Rep. 2024; 73(30):672-674.

PMID: 39088371 PMC: 11305408. DOI: 10.15585/mmwr.mm7330a3.


Volatile drug use and overdose during the first year of the COVID-19 pandemic in the United States.

Schneider K, Martin E, Allen S, Morris M, Haney K, Saloner B Int J Drug Policy. 2024; 126:104371.

PMID: 38447262 PMC: 11056297. DOI: 10.1016/j.drugpo.2024.104371.


Illicitly Manufactured Fentanyl-Involved Overdose Deaths with Detected Xylazine - United States, January 2019-June 2022.

Kariisa M, ODonnell J, Kumar S, Mattson C, Goldberger B MMWR Morb Mortal Wkly Rep. 2023; 72(26):721-727.

PMID: 37384558 PMC: 10328484. DOI: 10.15585/mmwr.mm7226a4.

References
1.
Kariisa M, Patel P, Smith H, Bitting J . Notes from the Field: Xylazine Detection and Involvement in Drug Overdose Deaths - United States, 2019. MMWR Morb Mortal Wkly Rep. 2021; 70(37):1300-1302. PMC: 8445380. DOI: 10.15585/mmwr.mm7037a4. View

2.
Reed M, Imperato N, Bowles J, Salcedo V, Guth A, Rising K . Perspectives of people in Philadelphia who use fentanyl/heroin adulterated with the animal tranquilizer xylazine; Making a case for xylazine test strips. Drug Alcohol Depend Rep. 2023; 4:100074. PMC: 9949306. DOI: 10.1016/j.dadr.2022.100074. View

3.
Sinclair M . A review of the physiological effects of alpha2-agonists related to the clinical use of medetomidine in small animal practice. Can Vet J. 2003; 44(11):885-97. PMC: 385445. View

4.
Friedman J, Montero F, Bourgois P, Wahbi R, Dye D, Goodman-Meza D . Xylazine spreads across the US: A growing component of the increasingly synthetic and polysubstance overdose crisis. Drug Alcohol Depend. 2022; 233:109380. PMC: 9128597. DOI: 10.1016/j.drugalcdep.2022.109380. View

5.
Monteiro E, Figueroa C, Choma J, Campagnol D, Bettini C . Effects of methadone, alone or in combination with acepromazine or xylazine, on sedation and physiologic values in dogs. Vet Anaesth Analg. 2008; 35(6):519-27. DOI: 10.1111/j.1467-2995.2008.00412.x. View